Autolus Therapeutics plc (AUTL)
NASDAQ: AUTL · Real-Time Price · USD
1.475
+0.055 (3.87%)
At close: Apr 28, 2026, 4:00 PM EDT
1.480
+0.005 (0.34%)
After-hours: Apr 28, 2026, 4:00 PM EDT
Autolus Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Revenue | 75.39 | 10.12 | 1.7 | 6.36 | 2.33 | Upgrade
|
| Revenue Growth (YoY) | 644.94% | 496.00% | -73.30% | 172.96% | 35.86% | Upgrade
|
| Cost of Revenue | 207.38 | 141.02 | 122.31 | 117.35 | 110.84 | Upgrade
|
| Gross Profit | -132 | -130.9 | -120.62 | -110.99 | -108.51 | Upgrade
|
| Selling, General & Admin | 138.2 | 110.11 | 54.91 | 31.9 | 31.87 | Upgrade
|
| Operating Expenses | 138.2 | 110.11 | 54.91 | 31.9 | 31.87 | Upgrade
|
| Operating Income | -270.2 | -241.01 | -175.53 | -142.89 | -140.37 | Upgrade
|
| Interest Expense | -42.37 | -39.94 | -45.07 | -8.91 | -1.11 | Upgrade
|
| Interest & Investment Income | 18.98 | 32.36 | 13.51 | 1.71 | 0.26 | Upgrade
|
| Currency Exchange Gain (Loss) | 2.16 | -0.99 | 2.64 | 1.8 | -2.3 | Upgrade
|
| Other Non Operating Income (Expenses) | 6.21 | 30.86 | 0.22 | 0.34 | 0.16 | Upgrade
|
| EBT Excluding Unusual Items | -285.21 | -218.72 | -204.23 | -147.95 | -143.36 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | -3.79 | -0.52 | -0.68 | Upgrade
|
| Asset Writedown | -0.35 | -0.41 | -0.38 | - | - | Upgrade
|
| Other Unusual Items | - | - | - | -0.1 | 2 | Upgrade
|
| Pretax Income | -285.56 | -219.13 | -208.4 | -148.57 | -142.04 | Upgrade
|
| Income Tax Expense | 1.97 | 1.53 | -0.02 | 0.27 | 0.06 | Upgrade
|
| Net Income | -287.53 | -220.66 | -208.38 | -148.84 | -142.1 | Upgrade
|
| Net Income to Common | -287.53 | -220.66 | -208.38 | -148.84 | -142.1 | Upgrade
|
| Shares Outstanding (Basic) | 266 | 255 | 174 | 95 | 72 | Upgrade
|
| Shares Outstanding (Diluted) | 266 | 255 | 174 | 95 | 72 | Upgrade
|
| Shares Change (YoY) | 4.30% | 46.69% | 83.11% | 31.78% | 39.81% | Upgrade
|
| EPS (Basic) | -1.08 | -0.86 | -1.20 | -1.57 | -1.97 | Upgrade
|
| EPS (Diluted) | -1.08 | -0.86 | -1.20 | -1.57 | -1.97 | Upgrade
|
| Free Cash Flow | -302.61 | -228.35 | -156.57 | -123.15 | -126.72 | Upgrade
|
| Free Cash Flow Per Share | -1.14 | -0.90 | -0.90 | -1.30 | -1.76 | Upgrade
|
| Gross Margin | -175.09% | - | - | - | - | Upgrade
|
| Operating Margin | -358.41% | -2381.54% | -10337.34% | -2246.74% | -6024.64% | Upgrade
|
| Profit Margin | -381.40% | -2180.45% | -12272.26% | -2340.24% | -6098.54% | Upgrade
|
| Free Cash Flow Margin | -401.41% | -2256.38% | -9221.02% | -1936.31% | -5438.54% | Upgrade
|
| EBITDA | -260.38 | -233.3 | -168.96 | -135.54 | -132.01 | Upgrade
|
| D&A For EBITDA | 9.81 | 7.72 | 6.57 | 7.36 | 8.37 | Upgrade
|
| EBIT | -270.2 | -241.01 | -175.53 | -142.89 | -140.37 | Upgrade
|
| Revenue as Reported | 75.39 | 10.12 | 1.7 | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.